APA (7th ed.) Citation

Xu, S., Yu, K., Liu, L., Wang, Q., Wu, X., Chen, Y., . . . Wu, H. (2026). Proteogenomic Characterization Reveals Subtype‐Specific Therapeutic Potential for HER2‐Low Breast Cancer. Advanced Science, 13(12), 1. https://doi.org/10.1002/advs.202513086

Chicago Style (17th ed.) Citation

Xu, Shouping, et al. "Proteogenomic Characterization Reveals Subtype‐Specific Therapeutic Potential for HER2‐Low Breast Cancer." Advanced Science 13, no. 12 (2026): 1. https://doi.org/10.1002/advs.202513086.

MLA (9th ed.) Citation

Xu, Shouping, et al. "Proteogenomic Characterization Reveals Subtype‐Specific Therapeutic Potential for HER2‐Low Breast Cancer." Advanced Science, vol. 13, no. 12, 2026, p. 1, https://doi.org/10.1002/advs.202513086.